XML 55 R40.htm IDEA: XBRL DOCUMENT v3.24.0.1
Summary of Significant Accounting Policies - Additional Information (Detail)
$ in Thousands
1 Months Ended 8 Months Ended 12 Months Ended
Jan. 31, 2022
USD ($)
Jun. 30, 2021
USD ($)
Jan. 31, 2020
USD ($)
Dec. 31, 2023
USD ($)
Segment
Dec. 31, 2022
USD ($)
Schedule Of Summary Of Significant Accounting Policies [Line Items]          
Number of operating segment | Segment       1  
Inventory       $ 146,362 $ 85,714
SFJ Agreement [Member]          
Schedule Of Summary Of Significant Accounting Policies [Line Items]          
Payment made under agreement $ 5,000 $ 4,000 $ 80,000 94,000  
Regulatory Approval Granted US Food and Drug Administration [Member]          
Schedule Of Summary Of Significant Accounting Policies [Line Items]          
Inventory       $ 19,400